With the amalgamation of biotechnology and Information technology (IT) the costs of research has been dramatically reduced and speed and efficiency of research and development (R&D) in life sciences has been increased. Life sciences R&D thus has opened up new challenges and opportunities for IT professionals. With this merger, it is expected from IT people to convert molecular information into meaningful digital format and know about the hidden information stored in the data generated from the various genomics and proteomics project going on throughout the world.
Neutragenomics, pharmacogenomics, genetic testing, gene therapy and recombinant DNA vaccines are newer areas of biotechnology. Newly developed bio-pharmaceutical method efficiently detects the genetic defects and can be treated even before the symptoms arise.
Bioinformatics focuses on the use of IT to collect, organize, store, interpret, share, and analyze biological data. IT companies are now aware that the life sciences market comprises only a small part of the total IT market but it is a vibrant market. The business of "Medical Bioinformatics," powered by strong and irreversible economic and scientific trends in our society, has the potential to be a multibillion dollar, non-polluting, high-wage service industry in the 10 - 20 year time-frame. To meet this exponential increase in the developmental pace and complexity, our society urgently needs to realign the design and infrastructure of higher education with the needs of the people.